Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice

Aim. Inflammation is important in heart failure (HF). The role of the immune receptor toll-like receptor 9 (TLR9) in HF is not understood and not investigated in diastolic HF. We investigated the role of TLR9 in a murine diastolic HF model caused by cardiomyocyte SERCA2a excision. Methods and Result...

Full description

Saved in:
Bibliographic Details
Main Authors: Yangchen Dhondup, Ivar Sjaastad, Øystein Sandanger, Jan Magnus Aronsen, Muhammad Shakil Ahmed, Håvard Attramadal, Alexandra Vanessa Finsen, Lili Zhang, Trine Ranheim, Katrine Alfsnes, Pål Aukrust, Geir Christensen, Arne Yndestad, Leif Erik Vinge
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/9450439
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558996775501824
author Yangchen Dhondup
Ivar Sjaastad
Øystein Sandanger
Jan Magnus Aronsen
Muhammad Shakil Ahmed
Håvard Attramadal
Alexandra Vanessa Finsen
Lili Zhang
Trine Ranheim
Katrine Alfsnes
Pål Aukrust
Geir Christensen
Arne Yndestad
Leif Erik Vinge
author_facet Yangchen Dhondup
Ivar Sjaastad
Øystein Sandanger
Jan Magnus Aronsen
Muhammad Shakil Ahmed
Håvard Attramadal
Alexandra Vanessa Finsen
Lili Zhang
Trine Ranheim
Katrine Alfsnes
Pål Aukrust
Geir Christensen
Arne Yndestad
Leif Erik Vinge
author_sort Yangchen Dhondup
collection DOAJ
description Aim. Inflammation is important in heart failure (HF). The role of the immune receptor toll-like receptor 9 (TLR9) in HF is not understood and not investigated in diastolic HF. We investigated the role of TLR9 in a murine diastolic HF model caused by cardiomyocyte SERCA2a excision. Methods and Results. We crossed SERCA2a KO and TLR9 KO mice to generate four mouse lines. Tamoxifen-induced cardiomyocyte SERCA2a gene excision was carried out in mice, causing diastolic HF. After 7.6 weeks, cardiac functions and dimensions were analyzed by echocardiography and heart tissues were processed. HF mice depleted of TLR9 demonstrated reduced survival compared to SERC2a KO mice, with a median life expectancy of 58 days compared to 63 days. Both HF groups displayed increased left atrium size, lung weight, fetal gene expressions, monocyte/macrophage infiltration, and fibrosis. However, there were no significant differences between the groups. Conclusion. In mice with SERCA2a KO-induced diastolic HF, the absence of TLR9 reduced median life expectancy. The cause remains elusive, as all investigated HF parameters were unaltered. Still, these findings support a salutary role of TLR9 in some subsets of HF conditions and underline the importance for future studies on the mechanisms of TLR9 in diastolic HF.
format Article
id doaj-art-574432b69998439ab5a5f81e21132c63
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-574432b69998439ab5a5f81e21132c632025-02-03T01:31:06ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/94504399450439Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure MiceYangchen Dhondup0Ivar Sjaastad1Øystein Sandanger2Jan Magnus Aronsen3Muhammad Shakil Ahmed4Håvard Attramadal5Alexandra Vanessa Finsen6Lili Zhang7Trine Ranheim8Katrine Alfsnes9Pål Aukrust10Geir Christensen11Arne Yndestad12Leif Erik Vinge13Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayCenter for Heart Failure Research, University of Oslo, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayInstitute for Experimental Medical Research, Oslo University Hospital, Ullevaal, Oslo, NorwayK.G. Jebsen Inflammation Research Center, University of Oslo, Oslo, NorwayK.G. Jebsen Inflammation Research Center, University of Oslo, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayCenter for Heart Failure Research, University of Oslo, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayCenter for Heart Failure Research, University of Oslo, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, NorwayAim. Inflammation is important in heart failure (HF). The role of the immune receptor toll-like receptor 9 (TLR9) in HF is not understood and not investigated in diastolic HF. We investigated the role of TLR9 in a murine diastolic HF model caused by cardiomyocyte SERCA2a excision. Methods and Results. We crossed SERCA2a KO and TLR9 KO mice to generate four mouse lines. Tamoxifen-induced cardiomyocyte SERCA2a gene excision was carried out in mice, causing diastolic HF. After 7.6 weeks, cardiac functions and dimensions were analyzed by echocardiography and heart tissues were processed. HF mice depleted of TLR9 demonstrated reduced survival compared to SERC2a KO mice, with a median life expectancy of 58 days compared to 63 days. Both HF groups displayed increased left atrium size, lung weight, fetal gene expressions, monocyte/macrophage infiltration, and fibrosis. However, there were no significant differences between the groups. Conclusion. In mice with SERCA2a KO-induced diastolic HF, the absence of TLR9 reduced median life expectancy. The cause remains elusive, as all investigated HF parameters were unaltered. Still, these findings support a salutary role of TLR9 in some subsets of HF conditions and underline the importance for future studies on the mechanisms of TLR9 in diastolic HF.http://dx.doi.org/10.1155/2017/9450439
spellingShingle Yangchen Dhondup
Ivar Sjaastad
Øystein Sandanger
Jan Magnus Aronsen
Muhammad Shakil Ahmed
Håvard Attramadal
Alexandra Vanessa Finsen
Lili Zhang
Trine Ranheim
Katrine Alfsnes
Pål Aukrust
Geir Christensen
Arne Yndestad
Leif Erik Vinge
Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
Mediators of Inflammation
title Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
title_full Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
title_fullStr Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
title_full_unstemmed Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
title_short Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
title_sort toll like receptor 9 promotes survival in serca2a ko heart failure mice
url http://dx.doi.org/10.1155/2017/9450439
work_keys_str_mv AT yangchendhondup tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT ivarsjaastad tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT øysteinsandanger tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT janmagnusaronsen tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT muhammadshakilahmed tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT havardattramadal tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT alexandravanessafinsen tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT lilizhang tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT trineranheim tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT katrinealfsnes tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT palaukrust tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT geirchristensen tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT arneyndestad tolllikereceptor9promotessurvivalinserca2akoheartfailuremice
AT leiferikvinge tolllikereceptor9promotessurvivalinserca2akoheartfailuremice